Dirk Brehmer
12Patents
2h-index
30Co-inventors
46Inventor score
Filing activity: Aug 25, 2016 → May 18, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11059850B2 | Spirobicyclic analogues | Chemistry; Metallurgy | 6 | Active |
| US10653711B2 | 6-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inhibitors | Chemistry; Metallurgy | 6 | Active |
| US11702441B2 | Spirobicyclic analogues | Chemistry; Metallurgy | 1 | Active |
| US11318157B2 | 6-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inhibitors | Chemistry; Metallurgy | 1 | Active |
| US10898504B2 | Substituted nucleoside analogues for use as PRMT5 inhibitors | Human Necessities | 0 | Active |
| US11999993B2 | Use of biomarkers in identifying cancer patients that will be responsive to treatment with a PRMT5 inhibitor | Emerging Cross-Sectional Technologies | 0 | Active |
| US11993614B2 | Monocyclic and bicyclic ring system substituted carbanucleoside analogues for use as PRMT5 inhibitors | Human Necessities | 0 | Active |
| US11279970B2 | Use of biomarkers in identifying cancer patients that will be responsive to treatment with a PRMT5 inhibitor | Emerging Cross-Sectional Technologies | 0 | Active |
| US11098062B2 | Monocyclic and bicyclic ring system substituted carbanucleoside analogues for use as PRMT5 inhibitors | Human Necessities | 0 | Active |
| US12145961B2 | Spirobicyclic analogues | Chemistry; Metallurgy | 0 | Active |
| US11571437B2 | Methods of treating cancer using PRMT5 inhibitors | Human Necessities | 0 | Active |
| US11883367B2 | 6-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.